logo

For the Inventor, By the Inventor

Tytherington, United Kingdom

Derrick F Jones

This inventor holds 13 USPTO granted patents. Top assignees: Imperial Chemical Industries Limited, Ici Americas, Inc.. Active years: 1979-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Derrick F Jones. Retrieved from https://idiyas.com/inventor/derrick-f-jones

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 99(Granted Patents)


Location History:

  • Wilmington, DE (US) (1979 - 1980)
  • Cheshire, GB (1984)
  • Tytherington, GB (1983 - 1987)
  • Macclesfield, GB (1982 - 1989)

Company Filing History:

goldMedal12 out of 3,840 
 
Imperial Chemical Industries Limited
 patents
silverMedal6 out of 432 
 
Ici Americas, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1979-1989

Loading Chart...
13 patents (USPTO):Explore Patents
1. 4795755 - Heterocyclic derivatives (1989-01-03),
2. 4748165 - Amidine derivatives (1988-05-31),
3. 4657908 - Carbonyl derivatives (1987-04-14),
4. 4570000 - Nitrogen heterocycles (1986-02-11),
5. 4496571 - Histamine H2-antagonists (1985-01-29),
6. 4464374 - Substituted guanidine derivatives, processes, pharmaceutical (1984-08-07),
7. 4463005 - Bicyclic guanidines (1984-07-31),
8. 4460584 - Nitrogen heterocycles (1984-07-17),
9. 4374836 - Antisecretory heterocyclic derivatives, process for their manufacture (1983-02-22),
10. 4342765 - Guanidine derivatives and pharmaceutical compositions containing them (1982-08-03),
11. 4315009 - Antisecretory guanidine derivatives and pharmaceutical compositions (1982-02-09),
12. 4234735 - Guanidino imidazoles and thiazoles (1980-11-18),
13. 4165377 - Guanidino imidazoles and thiazoles (1979-08-21),

Title: Derrick F Jones: Innovator in Pharmaceutical Chemistry

Introduction

Derrick F Jones is a notable inventor based in Tytherington, GB, recognized for his contributions to pharmaceutical chemistry. He holds a total of 13 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest inventions are two significant patents related to histamine H-2 antagonists that inhibit gastric acid secretion. The first patent focuses on heterocyclic derivatives, which include a guanidine derivative with specific structural formulas. This invention aims to provide effective pharmaceutical compositions for treating conditions related to gastric acid secretion. The second patent involves amidine derivatives, also functioning as histamine H-2 antagonists, with a similar goal of inhibiting gastric acid secretion. Both patents describe manufacturing processes and the pharmaceutically-acceptable acid-addition salts of these compounds.

Career Highlights

Derrick has worked with prominent companies in the chemical industry, including Imperial Chemical Industries Limited and ICI Americas, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Throughout his career, Derrick has collaborated with notable colleagues, including Keith Oldham and Tobias O Yellin. These partnerships have likely enriched his work and led to further advancements in his field.

Conclusion

Derrick F Jones exemplifies the spirit of innovation in pharmaceutical chemistry through his patents and collaborations. His work continues to impact the medical field positively, particularly in the development of treatments for gastric acid-related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…